50 news items
Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game
AZN
BAYRY
GSK
16 May 24
Sanofi gained access to Novavax’s innovative vaccine technology is one of the ways the French company is trying to find new growth avenues amid
Arvinas and Pfizer Announce Updated Clinical Data from Phase 1b Trial of Vepdegestrant in Combination with Palbociclib (IBRANCEĀ®)
ARVN
PFE
16 May 24
care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance
Will Pharma And Healthcare Have Competitive Edge In Cannabis Post-Rescheduling? Data Analytics Expert Weighs In
ABBV
CRBP
CRDL
14 May 24
driving innovation
ViiV Healthcare Announces Health Canada Approval for APRETUDE (Cabotegravir tablets and extended release injectable suspension) for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV
PFE
13 May 24
company has done before and take a new approach to deliver effective and innovative medicines for HIV treatment and prevention, as well as support
Astellas Showcases Scientific Advancements Across its Oncology Portfolio at 2024 ASCO Annual Meeting
ALPMY
PFE
13 May 24
new research from across its innovative portfolio of approved and investigational cancer therapies during the 2024 American Society of Clinical Oncology
agapepbv89knjipkx3npln0bm1 86e4v2
AZN
MRK
MRNA
8 May 24
collaboratively to develop innovative therapies and holistic approaches to manage cancer cachexia effectively." Active biotech and pharma companies
80q2sy0nvmzspiysew9mjn5ssnr5nuwb 2spfbv24cb5b
BNTX
PFE
6 May 24
. With a strong cash position of 16.9 billion euros, we are well positioned to invest in our innovative R&D pipeline and scale the business
m2h4lrr6mbnrrzn 7ebieelsj0rd86ulcpm
PFE
6 May 24
that Andrew Baum, M.D., will join the company as Chief Strategy and Innovation Officer, Executive Vice President. Dr. Baum will be a member
wivm5w8w4s xc4athhbnby3czj74tbeot33mow15nv31
PFE
1 May 24
Innovation
kjj2w m8tum43tmp34vo25o0vvjzb
ARVN
ATOS
ICCM
30 Apr 24
, Pfizer. "We are proud to continue our legacy of developing innovative treatment options for people impacted by metastatic breast cancer and look
sm84yj
ARVN
ATOS
ICCM
30 Apr 24
, Pfizer. "We are proud to continue our legacy of developing innovative treatment options for people impacted by metastatic breast cancer
r3yhxj111kefnr7hlp1tjqnysuyqj70uruo4wf3m6neboygd9mhsyt7
GMAB
PFE
29 Apr 24
towards improving the lives of patients through innovative and differentiated antibody therapeutics. For 25 years, its passionate, innovative
au9slm9ad9 0d
GMAB
PFE
29 Apr 24
unstoppable team to strive towards improving the lives of patients through innovative and differentiated antibody therapeutics. For 25 years, its passionate
ef3ianjaxdr1u2
GMAB
PFE
29 Apr 24
unstoppable team to strive towards improving the lives of patients through innovative and differentiated antibody therapeutics. For 25 years, its
09ceholol7ue02gtacddvbs dm9wo2gc76jontpvbuafx8kc
MRNA
MYNZ
PFE
29 Apr 24
When it comes to cancer, there’s innovation both on the diagnostics and the treatment front thanks to messenger RNA, or mRNA, a genetic
08a2mjp1 kbplwsj7bs1divjkpxhncm0
PFE
29 Apr 24
of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance
rdubfdxjv9psixoq6wx758tr u2
PFE
26 Apr 24
With BEQVEZ now approved for use, Pfizer is launching an innovative warranty program based on durability of patient response to treatment
tp8im98j8 wagqiw
PFE
26 Apr 24
is launching an innovative warranty program based on durability of patient response to treatment. The goal of the warranty is to provide greater
c9f9qp6y5gs42zk7jjchidy9o99dl6gs7631siokvjrqaudvo9gf550c8u
PFE
24 Apr 24
innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments
283lwhbi9vpzu5apjr ip5a24g468dwirybmg3wcfi138tf8xohctr
PFE
22 Apr 24
EMBLAVEO® was reviewed under European Medicines Agency accelerated assessment procedure, used when a pharmaceutical product is of major interest for public health and therapeutic innovation